Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?

Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?

There are no signs the coronavirus pandemic is slowing down in the U.S., with more than 1,100 Americans dying every day from COVID-19 in recent days. Beyond the staggering fatalities, one estimate by the Australian National University puts the virus' potential global economic damage at over $21 trillion. The need for a coronavirus vaccine has thus become paramount to saving lives and mitigating economic catastrophes.